Wednesday, September 30, 2015

Increasing Incidences of Spinal Disorders and Rising Adoption of Minimally Invasive and Non-fusion Spinal Procedures are Offering High-growth Opportunities for Market Players

Over the last few decades, the spinal implants and spinal devices market has witnessed significant technological advancements in terms of development of safer, cost-effective, and user-friendly medical devices. Increasing incidences of spinal disorders, rising geriatric and obese population, and continuous technological developments in spinal devices acted as major driving factors for the global spinal implants and spinal devices market. North America and Western European regions are mature markets for spinal implants and spinal devices. However, developing regions such as Asia-Pacific (including China, India, South Korea, and Taiwan) and Latin America are expected to grow at a higher rate and become new revenue-generating markets for players dealing with spinal implants and devices. The high-growth opportunities in the Asia-Pacific and Latin American regions is attributed to the rising healthcare expenditure, government initiatives, growing incidence and prevalence of spinal disorders, rising obese population, and increasing awareness among physicians and patients about the latest technological innovations.  

In the Asia-Pacific region, the spinal implants and spinal devices market in China is estimated to grow at the highest CAGR in the coming five years. Increasing government investments for the development of the country’s healthcare infrastructure are leading to growth in the number of healthcare service centers in China; thereby, rising the demand for spinal surgery devices in the country. In addition, increased government funding is also motivating private investors to make huge investments in China’s healthcare system. 

Moreover, presence of a large patient population, growing income levels, and rising prevalence of spinal disorders are fueling growth of the spinal implants and spinal devices market in China. Other Asian countries such as India, South Korea, and Taiwan are also expected to witness high growth in the forecast period, owing to the increasing government efforts to develop healthcare infrastructure and rising patient and physician education and awareness on the newly developed spine treatment procedures and technologies.
Technologically advanced non-fusion minimally invasive spinal implants and devices enable physicians to treat patients with more accuracy and efficiency. The market growth of these technologically advanced devices is primarily propelled by the increasing adoption of minimally invasive spine surgeries, as it reduces surgical risk, pain, blood loss, and risk of infection; and requires less time for recovery (leading to reduced time of post-operative hospital stays). Several companies such as Medtronic, plc (U.S.), DePuy Synthes (U.S.), Stryker Corporation (U.S.), NuVasive, Inc. (U.S.), K2M Group Holdings, Inc. (U.S.), and Globus Medical, Inc. (U.S.) are investing in this high-growth market to gain more profits and increase their shares in the spinal implants and spinal devices market.

Friday, September 25, 2015

Emerging Economies to Drive Growth of the Global Biomarkers Market Personalized Development a Key Growth Segment

North America accounted for the largest share of the global biomarkers market in 2015. However, the Asian market is expected to grow at the highest rate during the forecast period and represents new revenue pockets for the biomarkers market. The expansion of leading biomarkers companies in Asia will enhance the market in this region. According to the World Bank, R&D spending in this regional segment increased from $177 billion in 2003 to $329 billion in 2010, at a CAGR of 9.29%. In 2010, Asia accounted for 27.13% of the global R&D spending. Moreover, R&D spending accounted for 1.97% of Asia’s GDP in 2010. In Asia, Japan is noteworthy for its significant R&D expenditure, which was 14.75% of the global R&D spending in 2010. R&D spending accounted for 3.16% of Japan’s GDP in 2010. Growth in R&D expenditure, along with strong growth trends in the pharmaceutical and biotechnology industries, will drive the Asian biomarkers market.
The application segments of biomarkers will be important revenue pockets for the market in the forecast period (2015–2020), these being diagnostics development, drug discovery and development, personalized medicine, disease risk assessment, and others. Diagnostics development accounted for the largest share of the biomarkers market in 2015. However, personalized medicine is expected to grow at highest rate during the forecast period. Personalized medicine is gaining recognition due to the limitations of standard diagnosis and treatment methods; many areas of medicine, from cancer to immunological disorders, are moving towards tailored treatment for individuals based on their genetic signatures and clinical characteristics.

Thursday, September 24, 2015

New Product Launches is the Key Strategy Adopted by Leading Market Players to Bolster Growth in the Global 3D Printing Medical Devices Market

In 2014, the global 3D printing medical devices market was dominated by Stratasys Ltd. (Israel & U.S.) and 3D Systems Corporation (U.S.). These two companies accounted for a combined market share of ~57.0% of the global 3D printing medical devices market in 2014. Stratasys Ltd. held the leadership position in the global 3D printing medical devices market due to its well established distribution network and broad product portfolio. Stratasys’s portfolio includes a vast range of 3D printer series, comprising the idea series, design series, production series, and dental series; materials; and solutions. Its 3D printing solutions include rapid prototyping models, additive manufacturing devices, and consulting and advanced material solutions. Over the past three years, the company adopted the strategies of new product launches; distribution agreements, partnerships, and collaborations; and acquisitions to maintain its leadership position in the global 3D printing medical devices market.
3D Systems Corporation (U.S.) held the second position in the 3D printing medical devices market in 2014. The company has a wide geographical presence across the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Its robust product portfolio includes 3D printing solutions for surgical planning, simulation, training, and printing patient-specific medical and dental devices. The company pursues strategies such as new product launches, product enhancements, acquisitions, and agreements and collaborations to uphold its leading position in the global 3D printing medical devices market.

In the 3D printing medical devices market, leading players are adopting the strategies of new product launches; product portfolio enhancements; geographic expansions; agreements, partnerships, and collaborations, and mergers and acquisitions, in order to increase their market shares. Market players adopted these strategies to access new technologies, develop novel products, expand their product portfolios and distribution networks, and enter into growing markets. Leading players are also focusing on increasing their market visibility and strengthening their research and development capacities to develop innovative 3D printing products. In addition to the top market players, companies such as EnvisionTEC GmbH (Germany), EOS GmbH Electro Optical Systems (Germany), Renishaw plc (U.K.), Materialise NV (Belgium), 3T RPD, Ltd. (U.K.), Arcam AB (Sweden), Concept Laser GmbH (Germany), and Prodways (France) are primarily focuses on launching new 3D printers, materials, and software to widen their product offerings in the market.